Pneumeric, Inc.

Pneumeric, Inc. is a medical device company established in July 2021, dedicated to enhancing trauma care for tension pneumothorax, a serious lung condition. The company has exclusively licensed its core technology from Mayo Clinic and received FDA clearance for its flagship product, the Capnospot®, in March 2023. The Capnospot® is a portable device that attaches to any commercially available needle used for needle thoracostomy. It provides objective confirmation of correct needle placement by detecting carbon dioxide (CO2) from the pneumothorax, indicated by a clear color change. This innovation improves the accuracy of needle decompression, reducing the risk of treatment failures. The device is compatible with all decompression needles and operates effectively in low-light conditions, making it suitable for emergency medical situations. Pneumeric distributes its products through direct and indirect channels, including hospitals, emergency medical services, and military markets. The company has partnered with Naglreiter for manufacturing and adheres to ISO and FDA standards. Pneumeric aims to advance trauma care further and has been recognized with the 2023 EMS World Expo Innovation Award for its contributions to the field.

• Employees 3
• Founded 2021